Shockwave Medical Inc SWAV:NASDAQ

Last Price$57.21Cboe Real-Time Last Sale as of 3:15PM ET 6/24/19
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.43(0.75%)
Bid (Size)$57.12 (3)
Ask (Size)$57.53 (100)
Day Low / High$57.17 - 58.94
Volume234.0 K

View Medical Specialties IndustryPeer Comparison as of 06/24/2019


Shockwave Medical Inc ( NASDAQ )

Price: $57.21
Change: -0.43 (0.75%)
Volume: 234.0 K
3:15PM ET 6/24/2019

CareDx Inc ( NASDAQ )

Price: $34.92
Change: -3.11 (8.18%)
Volume: 439.7 K
3:29PM ET 6/24/2019

Atrion Corp ( NASDAQ )

Price: $894.89
Change: +7.46 (0.84%)
Volume: 5.4 K
3:24PM ET 6/24/2019

Inogen Inc ( NASDAQ )

Price: $70.99
Change: -0.34 (0.48%)
Volume: 225.8 K
3:28PM ET 6/24/2019

BioTelemetry Inc ( NASDAQ )

Price: $48.68
Change: -1.35 (2.70%)
Volume: 167.8 K
3:24PM ET 6/24/2019

Read more news Recent News

Shockwave Names Keith Dawkins as Chief Medical Officer
9:54AM ET 5/15/2019 MT Newswires

Shockwave Medical (SWAV), a medical device company, said Wednesday it has appointed Dr. Keith Dawkins as its chief medical officer. Prior to Shockwave,...

ShockWave Medical Touches Record High After Top-End 2019 Sales Guidance Almost Triples From Year Earlier
1:58PM ET 5/09/2019 MT Newswires

ShockWave Medical, Inc. (SWAV) shares surged more than 22% intraday, earlier touching their highest ever, after the company reported full-year 2019 revenue...

Sector Update: Health Care Stocks Slump in Late Trade
3:18PM ET 4/03/2019 MT Newswires

Top Health Care Stocks JNJ -0.53% PFE -0.61% ABT -0.44% MRK -0.16% AMGN -0.16% Health care stocks were sliding lower, including a 0.3% decline for...

Sector Update: Health Care Stocks Slip Wednesday Afternoon
2:07PM ET 4/03/2019 MT Newswires

Top Health Care Stocks JNJ -0.05% PFE -0.13% ABT -0.11% MRK +0.21% AMGN -0.04% Health care stocks were lower, including a 0.2% loss for...

Company Profile

Business DescriptionShockwave Medical, Inc. operates as a medical device company. It focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA. View company web site for more details
Address5403 Betsy Ross Drive
Santa Clara, California 95054
Number of Employees162
Recent SEC Filing05/09/201910-Q
President, Chief Executive Officer & DirectorDouglas Evan Godshall
Vice President-OperationsMike Maszy
Chief Financial officer & SecretaryDaniel Puckett
Vice President-Clinical AffairsBeaux Alexander

Company Highlights

Price Open$57.50
Previous Close$57.64
52 Week Range$24.58 - 68.39
Market Capitalization$1.6 B
Shares Outstanding28.0 M
SectorHealth Technology
IndustryMedical Specialties
Next Earnings Announcement08/14/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.32
Beta vs. S&P 500N/A
Revenue$12.3 M
Net Profit Margin-176.08%
Return on Equity-39.63%

Analyst Ratings as of 06/14/2019

Consensus RecommendationConsensus Icon
Powered by Factset